Posted by Michael Wonder on 10 Apr 2026
Wegovy injection becomes first GLP-1 weight-loss treatment approved for 48-hour controlled-temperature delivery in the EU
9 April 2026 - – The EMA has approved an update to the product information for Wegovy injection that allows the medicine to stay at a controlled temperature of up to 30°C for up to 48 hours during delivery, reducing distribution complexity for pharmacies and online partners.
This approval makes Wegovy the only GLP-1 for weight management with this flexibility in Europe.
